中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2009年
4期
326-329
,共4页
游震宇%王俊杰%赵勇%庄洪卿%刘峰%张颖东
遊震宇%王俊傑%趙勇%莊洪卿%劉峰%張穎東
유진우%왕준걸%조용%장홍경%류봉%장영동
内皮抑素%细胞系,人肺鳞状细胞癌%放射增敏%细胞凋亡%细胞周期
內皮抑素%細胞繫,人肺鱗狀細胞癌%放射增敏%細胞凋亡%細胞週期
내피억소%세포계,인폐린상세포암%방사증민%세포조망%세포주기
Endostatin%Cell lines,human lung squamous cell carcinoma%Radiosensitization%Cell apoptosis%Cell cycle
目的 探讨国产重组人内皮抑素是否对肺鳞癌细胞系H-520具有放射增敏作用.方法 取指数生长期的人肺鳞癌细胞系H-520细胞,用成克隆实验检测内皮抑素的细胞毒性和各实验组的克隆形成能力,计算各组细胞存活分数,利用多靶单击模型拟合细胞存活曲线.流式细胞术检测细胞凋亡、细胞周期分布变化及活化的Caspase蛋白片段水平.结果 成克隆实验中内皮抑素联合照射组较照射组D0、Dq、D10、SF2值均低,放射增敏比为1.50(D0值之比).流式细胞术检测细胞凋亡示内皮抑素+照射组细胞凋亡率分别为22.38%±1.61%、35.01%±1.16%、46.83%±2.06%、64.08%±4.28%,照射组分别为4.27%±0.29%、14.3%±1.15%、28.49%±1.58%、54.79%±1.89%,两组凋亡率差异有统计学意义(t=19.17、17.79、25.64、3.44,P值均<0.05).内皮抑素可诱导H-520细胞G0+G1阻滞,而照射则诱导G2+M期阻滞.内皮抑素+照射组活化Caspase蛋白片段表达增加(62.7%±1.9%)较对照组(12.1%±0.1%)、内皮抑素组(54.6%±1.0%)和照射组(34.1%±1.2%)显著增高(t=46.69、6.55、22.54,P值均<0.05;).结论 内皮抑素可通过抑制H-520细胞牛长、促进凋亡、细胞周期重分布来达到放射增敏作用.
目的 探討國產重組人內皮抑素是否對肺鱗癌細胞繫H-520具有放射增敏作用.方法 取指數生長期的人肺鱗癌細胞繫H-520細胞,用成剋隆實驗檢測內皮抑素的細胞毒性和各實驗組的剋隆形成能力,計算各組細胞存活分數,利用多靶單擊模型擬閤細胞存活麯線.流式細胞術檢測細胞凋亡、細胞週期分佈變化及活化的Caspase蛋白片段水平.結果 成剋隆實驗中內皮抑素聯閤照射組較照射組D0、Dq、D10、SF2值均低,放射增敏比為1.50(D0值之比).流式細胞術檢測細胞凋亡示內皮抑素+照射組細胞凋亡率分彆為22.38%±1.61%、35.01%±1.16%、46.83%±2.06%、64.08%±4.28%,照射組分彆為4.27%±0.29%、14.3%±1.15%、28.49%±1.58%、54.79%±1.89%,兩組凋亡率差異有統計學意義(t=19.17、17.79、25.64、3.44,P值均<0.05).內皮抑素可誘導H-520細胞G0+G1阻滯,而照射則誘導G2+M期阻滯.內皮抑素+照射組活化Caspase蛋白片段錶達增加(62.7%±1.9%)較對照組(12.1%±0.1%)、內皮抑素組(54.6%±1.0%)和照射組(34.1%±1.2%)顯著增高(t=46.69、6.55、22.54,P值均<0.05;).結論 內皮抑素可通過抑製H-520細胞牛長、促進凋亡、細胞週期重分佈來達到放射增敏作用.
목적 탐토국산중조인내피억소시부대폐린암세포계H-520구유방사증민작용.방법 취지수생장기적인폐린암세포계H-520세포,용성극륭실험검측내피억소적세포독성화각실험조적극륭형성능력,계산각조세포존활분수,이용다파단격모형의합세포존활곡선.류식세포술검측세포조망、세포주기분포변화급활화적Caspase단백편단수평.결과 성극륭실험중내피억소연합조사조교조사조D0、Dq、D10、SF2치균저,방사증민비위1.50(D0치지비).류식세포술검측세포조망시내피억소+조사조세포조망솔분별위22.38%±1.61%、35.01%±1.16%、46.83%±2.06%、64.08%±4.28%,조사조분별위4.27%±0.29%、14.3%±1.15%、28.49%±1.58%、54.79%±1.89%,량조조망솔차이유통계학의의(t=19.17、17.79、25.64、3.44,P치균<0.05).내피억소가유도H-520세포G0+G1조체,이조사칙유도G2+M기조체.내피억소+조사조활화Caspase단백편단표체증가(62.7%±1.9%)교대조조(12.1%±0.1%)、내피억소조(54.6%±1.0%)화조사조(34.1%±1.2%)현저증고(t=46.69、6.55、22.54,P치균<0.05;).결론 내피억소가통과억제H-520세포우장、촉진조망、세포주기중분포래체도방사증민작용.
Objective To investigate the radiosensitising effect of recombinant human endostatin (endostar) on human lung squamous cancer cell line H-520 in vitro and its mechanism. Methods H-520 cells in exponential growing phase were treated with endostar alone, irradiation alone, or endostar plus irra-diation. Colony-forming assay was used to investigate the cytotoxicity and radiosensitising effects of endostar. Cell survival fractions of all groups were calculated and cell survival curves were fitted by single-hit multi-tar-get model. Cell apoptosis, cell cycle distribution and activated Caspase expression level were investigated by flow cytometry. Results The D0, Dq, D10 and SF2 values of combined treatment group were much lower than those of irradiation alone group. The sensitization enhancement ratio (SER) was 1.50 (ratio of D0 values). Endnstar induced H-520 cell apoptosis in a dose dependant manner. After administration of endostar, H-520 cell proliferation was inhibited, and cell apoptosis rate and apoptotic bodies were increased. After irradiation of 0 Gy, 2 Gy, 4 Gy and 8 Gy, the apoptosis rate of H-520 cells was 4.27% ±0.29%, 14.3% ±1.15%, 28.49% ± 1.58% and 54.79% ± 1.89% in the radiotherapy alone group, and 22.38% ± 1.61%, 35.01% ±1.16%, 46.83%±2.06% and 64.08%±4.28% in the combined treatment group, respective-ly. The difference between the two groups was significant (t = 19.17, 17.79, 25.64 and 3.44,all P < 0.05 ). Flow cytometric analysis showed that cell cycle distribution changed and G0 + G1 phase arrest oc-curred after endostar treatment, while irradiation induced G2 + M arrest. The expression level of activated Caspase in combination group (62.7% ±1.9% ) was higher compared to the control group ( 12.1%± 0. 1% ) , endostar alone group ( 54.6% ±1.0% ) and irradiation alone group ( 34.1%±1.2% ) ( t = 46.69, 6.55 and 22.54 ; all P < 0.05 ). Conclusion Endostar can enhance the radiosensitivity of H-520 ceils by inhibiting cell proliferation, promoting cell apoptosis and facilitating cell cycle redistribution.